Min­eralys aims to raise $250M; Co­herus dis­clos­es lay­offs

Plus, news about BioN­Tech, Roche, Boehringer In­gel­heim, Cer­voMed, Gen­mab, In­ozyme Phar­ma, Va­lo Ther­a­peu­tics and Agomab:

Min­eralys Ther­a­peu­tics’ $250M fol­low-on of­fer­ing: Stel­lar Phase …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER